TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
- PMID: 35083778
- DOI: 10.1002/ajh.26479
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
References
REFERENCES
-
- Malcikova J, Tausch E, Rossi D, et al. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia. 2018;32(5):1070-1080. doi:10.1038/s41375-017-0007-7
-
- Doffe F, Carbonnier V, Tissier M, et al. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death Differ. 2021;28(5):1477-1492. doi:10.1038/s41418-020-00672-0
-
- Soussi T, Leroy B, Devir M, Rosenberg S. High prevalence of cancer-associated TP53 variants in the gnomAD database: a word of caution concerning the use of variant filtering. Hum Mutat. 2019;40(5):516-524. doi:10.1002/humu.23717
-
- Canadillas JM, Tidow H, Freund SM, et al. Solution structure of p53 core domain: structural basis for its instability. Proc Natl Acad Sci U S A. 2006;103(7):2109-2114.
-
- Kotler E, Shani O, Goldfeld G, et al. A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation. Mol Cell. 2018;71(1):178-190.e8. doi:10.1016/j.molcel.2018.06.012
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous